26 filings
8-K
PEARQ
Pear Therapeutics, Inc.
10 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:36pm
8-K
PEARQ
Pear Therapeutics, Inc.
7 Apr 23
Termination of a Material Definitive Agreement
11:32am
8-K
PEARQ
Pear Therapeutics, Inc.
17 Mar 23
Pear Therapeutics Announces Process Exploring Strategic Alternatives
9:17am
8-K
PEARQ
Pear Therapeutics, Inc.
24 Feb 23
Departure of Directors or Certain Officers
4:05pm
8-K
PEARQ
Pear Therapeutics, Inc.
3 Jan 23
Entry into a Material Definitive Agreement
6:33am
8-K
sbazgtner9vp4iclq0
14 Nov 22
Pear Therapeutics Reports Third Quarter 2022 Results
4:05pm
8-K
uhqgqw9lva1a6
11 Aug 22
Pear Therapeutics Reports Second Quarter 2022 Results
4:03pm
8-K
b2vrgqkl0y34qtyv 5hw
25 Jul 22
Cost Associated with Exit or Disposal Activities
4:01pm
8-K
9jdnu2fn
24 Jun 22
Regulation FD Disclosure
5:23pm
8-K
st9atz1kktl9hc
15 Jun 22
Pear Therapeutics Announces Three New Board Members
8:04am
8-K
2jamzbr
6 Jun 22
Regulation FD Disclosure
9:46am
8-K
fz6mc 7ylmd6d7a3
16 May 22
Pear Therapeutics Reports First Quarter 2022 Financial Results
4:03pm
8-K
xye 2ipfw
12 May 22
Departure of Directors or Certain Officers
7:00am
8-K/A
82y9yor9hvkrz92r
28 Mar 22
Pear Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
5:59pm
8-K
p5w5a5qd ajck2ttu2uj
28 Mar 22
Pear Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
4:05pm
8-K
z7kf 1fib8
18 Jan 22
Pear Therapeutics Announces Operational Performance Metrics for Full Year 2021 and Reaffirms Financial and Operational Performance Metrics for Full Year 2022
8:01am
8-K
e4bk vghm4ylo6q3
11 Jan 22
Results of Operations and Financial Condition
4:45pm
8-K
tbgmk40th3hm2wsk5c
8 Dec 21
Index to Unaudited Condensed Consolidated Financial Statements
12:00am
8-K
mt5jy
30 Nov 21
Submission of Matters to a Vote of Security Holders
4:38pm
8-K
k6fu1
23 Nov 21
Submission of Matters to a Vote of Security Holders
5:16pm